In our next edition of our “Meet the Team Series”, we talk to Meena Shemar, who leads the early stage lateral flow development at our Birmingham office.
What does a normal day entail for you?
“I manage the early phase R&D activities on a number of different lateral flow assay projects. As a result, each day is unique and presents with various challenges, which I enjoy. I may be in the lab one day, attending customer meetings another day or drafting project plans, it’s extremely varied.”
What do you like most about working at Abingdon Health?
“I work with a group of very talented people who are passionate about what they do, which I think is fantastic. It’s nice to continually see the R&D team grow and develop; being part of that is rewarding. Abingdon Health really strives to ensure that each individual has the opportunity to meet their full potential.”
What are the 3 most important things to know when developing a quantitative lateral flow assay?
“I would consider the following three factors, Firstly, a calibration curve would be required for this; it is important to source suitable calibrator standards that cover the desired assay measuring range. Secondly, selecting suitable raw materials such as the label (i.e. gold, latex) and antibodies. Both can have a profound effect on the assay performance, for example, antibodies with higher affinity are capable of detecting much lower levels of the detection analyte. Thirdly, it is important to choose a lateral flow reader capable of detecting the label with an optimal spectral match, wide dynamic range and precision.”
What are your interests outside of work?
“I really enjoy hiking and being outdoors. I also like baking, I spend a lot of weekends at my sister’s coffee shop making cakes and finding new and exciting recipes to try, I also enjoy the free coffee I get!”.